Live Breaking News & Updates on Medica Therapeutics

Stay updated with breaking news from Medica therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Craig Hallum , Diamedica Therapeutics Company Profile , Diamedica Therapeutics Inc , Diamedica Therapeutics , Get Free Report , Medica Therapeutics , Medica Therapeutics Inc , Diamedica Therapeutics Daily ,

DiaMedica Therapeutics (DMAC) Set to Announce Earnings on Wednesday

DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. DiaMedica Therapeutics (NASDAQ:DMAC […] ....

Craig Hallum , Diamedica Therapeutics Inc , Diamedica Therapeutics , Get Free Report , Medica Therapeutics , Medica Therapeutics Inc , Diamedica Therapeutics Daily , Nasdaq Dmac ,

Craig Hallum Begins Coverage on DiaMedica Therapeutics (NASDAQ:DMAC)

Craig Hallum Begins Coverage on DiaMedica Therapeutics (NASDAQ:DMAC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Craig Hallum , Stonebridge Capital Advisors , Diamedica Therapeutics Inc , Paragon Associates Ii Joint Venture , Avantax Advisory Services Inc , Diamedica Therapeutics , Free Report , Medica Therapeutics , Get Free Report , Capital Advisors , Paragon Associates , Avantax Advisory Services , Medica Therapeutics Inc , Diamedica Therapeutics Daily ,

Craig Hallum Lowers DiaMedica Therapeutics (NASDAQ:DMAC) Price Target to $8.00

DiaMedica Therapeutics (NASDAQ:DMAC – Free Report) had its target price trimmed by Craig Hallum from $11.00 to $8.00 in a research note published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Separately, Oppenheimer reiterated an outperform rating and issued a $6.00 price objective (down previously from $7.00) on […] ....

Craig Hallum , Avantax Advisory Services Inc , Citadel Advisors , Stonebridge Capital Advisors , Diamedica Therapeutics Inc , Diamedica Therapeutics , Free Report , Medica Therapeutics , Get Free Report , Street Group , Advisory Services , Medica Therapeutics Inc , Diamedica Therapeutics Daily ,